中国老年人疫苗接种的现状、挑战和建议

2022-08-22 中国疫苗和免疫

老年人群传染病的疾病负担高而且治疗和康复难度大。常见疫苗可预防传染病如流感、肺炎球菌疾病、带状疱疹等对老年人健康造成重大威胁，而接种疫苗是预防这些疾病最经济有效的手段。目前中国老年人预防接种服务可及性

中文标题：

中国老年人疫苗接种的现状、挑战和建议

发布机构：

发布日期：

2022-08-22

简要介绍：

老年人群传染病的疾病负担高而且治疗和康复难度大。常见疫苗可预防传染病如流感、肺炎球菌疾病、带状疱疹等对老年人健康造成重大威胁，而接种疫苗是预防这些疾病最经济有效的手段。目前中国老年人预防接种服务可及性差，疫苗接种率较低。本文根据现有国内外文献，对中国老年人疫苗接种的现状和挑战进行了综述，对老年人疫苗接种提出了相关建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=7e5d91c0026203af, title=中国老年人疫苗接种的现状、挑战和建议, enTitle=, guiderFrom=中国疫苗和免疫, authorId=0, author=, summary=老年人群传染病的疾病负担高而且治疗和康复难度大。常见疫苗可预防传染病如流感、肺炎球菌疾病、带状疱疹等对老年人健康造成重大威胁，而接种疫苗是预防这些疾病最经济有效的手段。目前中国老年人预防接种服务可及性, cover=https://img.medsci.cn/Random/multiple-sclerosis-s14-doctor-speaking-with-patient.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Aug 22 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">老年人群传染病的疾病负担高而且治疗和康复难度大。常见疫苗可预防传染病如流感、肺炎球菌疾病、带状疱疹等对老年人健康造成重大威胁，而接种疫苗是预防这些疾病最经济有效的手段。目前中国老年人预防接种服务可及性差，疫苗接种率较低。本文根据现有国内外文献，对中国老年人疫苗接种的现状和挑战进行了综述，对老年人疫苗接种提出了相关建议。 </span></p>, tagList=[TagDto(tagId=7819, tagName=疫苗接种), TagDto(tagId=459913, tagName=老年人疫苗接种)], categoryList=[CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=107875, articleKeyword=中老年人疫苗, articleKeywordNum=6, guiderKeywordId=107875, guiderKeyword=中老年人疫苗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8641, appHits=121, showAppHits=0, pcHits=886, showPcHits=8520, likes=0, shares=3, comments=6, approvalStatus=1, publishedTime=Fri Aug 26 09:27:00 CST 2022, publishedTimeString=2022-08-22, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=lixiang, createdTime=Wed Aug 24 11:10:09 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 09:07:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国老年人疫苗接种的现状、挑战和建议_王雯.pdf)])

中国老年人疫苗接种的现状、挑战和建议_王雯.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2126507, encodeId=717e212650e23, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:34:55 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126506, encodeId=a67821265067c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:32:30 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2121676, encodeId=ab4821216e626, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Fri Mar 24 22:29:39 CST 2023, time=2023-03-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120440, encodeId=936a2120440f7, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:41:44 CST 2023, time=2023-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120441, encodeId=ec76212044149, content=针对老人治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:42:07 CST 2023, time=2023-03-19, status=1, ipAttribution=上海)]
2023-04-17 12b7ea7bm59暂无昵称来自江苏省

学习一下

49 0
[GetPortalCommentsPageByObjectIdResponse(id=2126507, encodeId=717e212650e23, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:34:55 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126506, encodeId=a67821265067c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:32:30 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2121676, encodeId=ab4821216e626, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Fri Mar 24 22:29:39 CST 2023, time=2023-03-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120440, encodeId=936a2120440f7, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:41:44 CST 2023, time=2023-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120441, encodeId=ec76212044149, content=针对老人治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:42:07 CST 2023, time=2023-03-19, status=1, ipAttribution=上海)]
2023-04-17 12b7ea7bm59暂无昵称来自江苏省

学习学习

46 0
[GetPortalCommentsPageByObjectIdResponse(id=2126507, encodeId=717e212650e23, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:34:55 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126506, encodeId=a67821265067c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:32:30 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2121676, encodeId=ab4821216e626, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Fri Mar 24 22:29:39 CST 2023, time=2023-03-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120440, encodeId=936a2120440f7, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:41:44 CST 2023, time=2023-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120441, encodeId=ec76212044149, content=针对老人治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:42:07 CST 2023, time=2023-03-19, status=1, ipAttribution=上海)]
2023-03-24 ms8000000684966679 来自上海

学习学习！

100 0
[GetPortalCommentsPageByObjectIdResponse(id=2126507, encodeId=717e212650e23, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:34:55 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126506, encodeId=a67821265067c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:32:30 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2121676, encodeId=ab4821216e626, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Fri Mar 24 22:29:39 CST 2023, time=2023-03-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120440, encodeId=936a2120440f7, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:41:44 CST 2023, time=2023-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120441, encodeId=ec76212044149, content=针对老人治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:42:07 CST 2023, time=2023-03-19, status=1, ipAttribution=上海)]
2023-03-19 ms8000000684966679 来自上海

学习一下！

68 0
[GetPortalCommentsPageByObjectIdResponse(id=2126507, encodeId=717e212650e23, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:34:55 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126506, encodeId=a67821265067c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa83166610, createdName=12b7ea7bm59暂无昵称, createdTime=Mon Apr 17 14:32:30 CST 2023, time=2023-04-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2121676, encodeId=ab4821216e626, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Fri Mar 24 22:29:39 CST 2023, time=2023-03-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120440, encodeId=936a2120440f7, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:41:44 CST 2023, time=2023-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2120441, encodeId=ec76212044149, content=针对老人治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20228578455, createdName=ms8000000684966679, createdTime=Sun Mar 19 16:42:07 CST 2023, time=2023-03-19, status=1, ipAttribution=上海)]
2023-03-19 ms8000000684966679 来自上海

针对老人治疗

88 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

预防公卫指南

中国老年人疫苗接种的现状、挑战和建议

相关指南

拓展阅读

科室

工具

服务